The future of hybrid HCP engagement with GSK, MSD, Novartis and McKinsey


Hybrid. Who knew a year ago this unremarkable word would have such a large part to play in pharma’s future lexicon and strategy building? Executives across the industry are working tirelessly to devise and execute a model in which pharma sales reps and other customer facing roles balance face-to-face (F2F), remote, and digital engagement.

Many questions remain unanswered; what is the right balance of F2F and remote engagement?

How do you create and maintain new relationships in the remote environment? How can we demonstrate what does – and doesn’t – and rapidly adapt and improve? Find out answers in this webinar Hybrid: Go-To-Market Models, Roles, and Capabilities for HCP Engagement.

Sign up now to join the session on Wednesday 5 May 2021 at 9 am EST/ 2pm BST/ 3pm CET.

Gain insight from this exclusive line-up of senior level executives:

  • George Katzourakis, SVP, Head of EuropeGSK
  • Cyril Schiever, SVP, President Mid-Europe RegionMSD
  • Janneke van der Kamp, Head Region EuropeNovartis
  • Brent Hooper, PartnerMcKinsey
  • Christina Hoffmann, Associate PartnerMcKinsey

Join the discussion to learn how to combine F2F, remote, and digital engagement strategies.

Don’t miss what is sure to be a popular session – sign up now.

Thanks to Matt Atkinson, Global Project Director, Reuters Events Pharma. If you have any questions, don’t hesitate to contact him at

Kind regards,

Lucy Muñiz
The Pharmaceutical Marketing Group